We would love to hear your thoughts about our site and services, please take our survey here.
Not reminding anyone, they did an article and the price surged from I think 100 to 285 give or take very quickly. My point still stands. Once mainstream media are given the green light to discuss this cancer treatment and the patients involved, hopefully many success stories, the sentiment will turn instantly. Thorn, Avacta announcing real life patient success stories on sky news would certainly not suit your agenda of driving the price down. 🤣🤣👍
“IMO probably untrue”
You did see what happened when the huff post did an article on Avacta? cancer is an extremely hot topic with the British people at the moment with Royal family etc. Any positive media campaign would have a significant impact on sentiment here imo. As I said they have more important things to be getting on with though.
“AVCT is not under any radar”
Totally agree within the niche investment community. However Avacta hasn’t approached MSM yet. I wonder what would be the impact on sentiment and short term price action if they did an interview with sky news explaining some of the positive case studies. People are very much in the dark, about this company and its potential. Avacta could easily solve sentiment overnight by doing a media campaign, however I feel they have more important things to do at the moment. I would keep that in mind though…. Media coverage will eventually happen.
windy not getting into this but you focus on micro bs hypothetical scenarios, forgetting that we are fully funded awaiting more confirmation of the science. (this is a pharma company it is all about the science). let’s have another conversation when the 2w results get published mid year if you are still around and not pestering some other bb pretending to be a hero with no agenda. in the meantime enjoy getting your posts deleted and totally ignored or ****ged off here. 🤘👋
You are trying to drive the share price down🤣💯 You admitted on several occasions are not invested currently. Why are you here otherwise? The agenda is so 🙄🙄 even wanting some HC calculations at 20-10p. Come on..🤣🤣👍
Haha Thorn you are in your element today.
1. We are fully funded, with clear milestones in place.
2. You have interlocked share price and sentiment with company success. Which is not the case.
3. You don’t have a clue what commercial discussions are taking place.
Anyone that takes you seriously shouldn’t be investing in AIM. You certainly don’t hide your agenda that’s for sure. 👍
What’s the rush on deals anyways, we are fully funded going into the pivotal efficacy stage of human trials. We all need to think logically, the more positive data we have available the better the deals we will get longer term. Short term share volatility is only relevant if you are trading or need to sell up, it doesn’t reflect the success the company is going to get if the FDA approves AVA6000. 💯👍
Not long to wait, until these are released. As the 2w trials will be done in parallel with one another rather than sequential, we will get results pretty soon. As the criteria for selection is strict and designed for success. We will likely see more evidence of efficacy data. Lot’s of news flow due in the next several months. Well funded, moving in the correct direction. Sentiment imo is why we are still at the placing price. (50% discount from our magnet price of 100 for 19-20% dilution). Sentiment can easily turn overnight and what better way to achieve that, than keep proving the platform works. FDA approved oncology drugs are worth a fortune, many multiples of our current mkt cap alone. Exciting summer ahead imo. 😊👍💯
Found it interesting Dr Smith mentioned real world evidence on the Q&A presentation, doing some research on this topic and you have an entire section on this subject by the FDA.
https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence
You can go down the rabbit hole few pdf documents to read, however it’s clear Avacta and the FDA are working together to generate real data, to back up the case for approval.
Bring it back on topic then you muppet, seriously BV you love to comment stay on the sidelines answer windy and thorn when you see fit, yet you refuse to keep me filtered, why is that? If you don’t like what I post bin me simple solution… 🤣💯👍
Do you think Avacta will run out of money before they get FDA approval?
Sorry to blow your bubble, however we are well funded moving into a pivotal trial and commercialisation 2026. The FDA will approve AVA6000 once they are ready, as i said previously on AVA6000 approval, this will open up serious commercial opportunities. So windy I assume that because you are focussing on the money aspect you can’t actually give me an answer on why the FDA will fail this based on the science. Totally blowing your arguments out of the water, because if you believe the FDA will approve on the science everything else will come good eventually.
I’m talking about the odds of failure. FDA approval for any Oncology drug, solves loads of problems regarding commercialisation that’s true for any pharmaceutical company. So if the odds of success are greater than failure for FDA approval, and AVA6000 gets approved everything else will fall into place.
“I do think the odds on failure are greater that success but thats based on stats. (And also backed up be a seemingly never ending SP decline as the trial progresses.)”
Oh windy more BS…..
The FDA don’t care about general stats of previous drug approvals or money or even share price. We are talking about AVA6000. Put a case together for the FDA not approving AVA6000. I’m talking about FDA approval only. Nothing to do with commercialisation. Let’s concentrate on the FDA approval millstone only from a scientific perspective. The floor is yours 👍👍